p53 Exon 4 (codon 72) Polymorphism and Exon 7 (codon 249) Mutation in Breast Cancer Patients in Southern Region(Madurai) of Tamil Nadu |
Vijayaraman, Kiruthiga Perumal
(Department of Biotechnology, Alagappa University)
Veluchamy, Mohanasundari (Department of Biotechnology, Alagappa University) Murugesan, Pravina (Department of Biotechnology, Alagappa University) Shanmugiah, Karutha Pandian (Department of Biotechnology, Alagappa University) Kasi, Pandima Devi (Department of Biotechnology, Alagappa University) |
1 | Pugalendhi P, Manoharan S, Baskaran N, et al (2010). Effects of genistein and daidzein, in combination, on the expression pattern of biomolecular markers (p53, PCNA, VEGF, iNOS, Bcl-2, and Bax) during 7, 12-dimethylbenz (a) anthracene (DMBA) induced mammary carcinogenesis in Sprague- Dawley rats. Int J Biol Med Res, 1, 264-71. |
2 | Pushkala K, Gupta PD (2009). Prevalence of breast cancer in menopausal blind women. Int J Med Sci, 1, 425-31. |
3 | Singh V, Rastogi N, Mathur N, et al (2008). Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women. Ann Epidemiol, 18, 48-57. DOI |
4 | Sjalander A, Birgander R, Hallmans G, et al (1996). p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis, 17, 1313-16. DOI ScienceOn |
5 | Suspitsin EN, Buslov KG, Grigoriev MY, et al (2003). Evidence against involvement of p53 polymorphism in breast cancer predisposition. Int J Cancer, 103, 431-3. DOI |
6 | Takiar R, Nadayil D, Nandakumar A (2010). Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev, 11, 1045-9. |
7 | Thorlacius S, Börresen AL, Eyfjörd JE (1993). Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Cancer Res, 53, 1637-41. |
8 | Weir R, Day P, Ali W (2007). Risk factors for breast cancer in women. A systematic review of the literature. NZHTA Report, 10. |
9 | Abdaheer S, Khan E (2009). Shape based classification of breast tumors using fractal analysis. IEEE, 272-5. |
10 | Alawadi S, Ghabreau L, Alsaleh M, et al (2010). P53 gene polymorphisms and breast cancer risk in Arab women. Med Oncol, 28, 709-15. |
11 | Andersen TI, Holm R, Nesland JM, et al (1993). Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer, 68, 540-8. DOI |
12 | Beckman G, Birgander R, Sjalander A, et al (1994). Is p53 polymorphism maintained by natural selection? Hum Hered, 44, 266-70. DOI ScienceOn |
13 | Buyru N, Tigli H, Dalay N (2003). P53 codon 72 polymorphism in breast cancer. Oncol Rep, 10, 711-4. |
14 | Chen FM, Hou MF, Wang JY, et al (2004). High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan. Cancer Lett, 207, 59-67. DOI |
15 | Chopra R (2001). The Indian scene. J Clin Oncol, 19, 106s-11s. |
16 | Chosdol K, Ahuja A, Rathore A, et al (2002). Study of p53 codon 72 polymorphism in various etnic groups of North India. Curr Sci, 82, 1253-5. |
17 | Coursaget P, Depril N, Chabaud M, et al (1993). High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br J Cancer, 67, 1395-7. DOI |
18 | Gohrke WS, Rebbeck TR, Besenfelder W, et al (1998). p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res, 18, 2095-9. |
19 | Damin APS, Frazzon APG, Damin DC, et al (2006). Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Cancer Detect Prev, 30, 523-9. DOI |
20 | Ganjewala D (2009). Prevalence of cancers in some parts of Madhya Pradesh and Uttar Pradesh in India. Acad J Cancer Res, 2, 12-8. |
21 | Hsu IC, Metcalf RA, Sun T, et al (1991). Mutational hot spot in the p53 gene in human hepatocellular carcinomas. Nature, 350, 427-8. DOI ScienceOn |
22 | Hussain SP, Amstad P, Raja K, et al (2001). Mutability of p53 hotspot codons to benzo (a) pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res, 61, 6350-5. |
23 | Igetei R, Otegbayo JA, Ndububa DA, et al (2008). Detection of p53 codon 249 mutation in Nigerian patients with hepatocellular carcinoma using a novel evaluation of cellfree DNA. Ann Hepatol, 7, 339-44. |
24 | Jeffreys AJ, Morton DB (1987). DNA fingerprints of dogs and cats. Anim Genet, 18, 1-15. |
25 | Kalemi TG, Lambropoulos AF, Gueorguiev M, et al (2005). The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Letters, 222, 57-65. DOI |
26 | Katiyar S, Dash BC, Thakur V, et al (2000). P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Cancer, 88, 1565-73. DOI |
27 | Keshava C, Frye BL, Wolff MS, et al (2002). Waf-1 (p21) and p53 polymorphisms in breast cancer. Cancer Epidemiol Biomarkers Prev, 11, 127-30. |
28 | Makwane N, Saxena A (2009). Study of mutations in p53 tumour suppressor gene in human sporadic breast cancers. IJCB, 24, 223-8. |
29 | Liu H, Wang Y, Zhou Q, et al (2002). The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China. World J Gastroenterol, 8, 480-2. DOI |
30 | Mabrouk I, Baccouche S, El Abed RYM, et al (2003). No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann NY Acad Sci, 1010, 764-70. DOI |
31 | Mirmomeni MH, Arveisi S, Ghobadi S, et al (2009). An investigation of point mutations at 7th exon of gene P53 in Hepatocellular Carcinoma patients in Kermanshah Province and the study of mutation in liver specimens of mice exposed to aflatoxin B1. Res J Biol Sci, 4, 107-12. |
32 | Nogueira JA, Ono-Nita SK, Nita ME, et al (2009). 249 TP 53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients. BMC Cancer, 9, 204. DOI ScienceOn |
33 | Noma C, Miyoshi Y, Taguchi T, et al (2004). Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Cancer Letters, 210, 197-03. DOI |
34 | Ohayon, T, Baruch GR, Papa MZ, et al (2005). The R72P P53 mutation is associated with familial breast cancer in Jewish women. Br J Cancer, 92, 1144-8. DOI |
35 | Papadakis EN, Dokianakis DN, Spandidos DA (2000). p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun, 3, 389-2. DOI ScienceOn |
36 | Peng XM, Peng WW, Yao JL (1998). Codon 249 mutations of p53 gene in development of hepatocellular carcinoma. World J Gastroenterol, 4, 125-7. |